Records containing: SARS-CoV2
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-11-20Seroprevalence of Anti-SARS-CoV2 Among Children According to Parents' SARS-CoV2 Serological Status. Study in a Hospital Population Assistance Publique-Hôpitaux Paris
-
CLINICAL_TRIALS study record update · 2025-10-22A Phase 2b, Double-Blind, Multi-Center, Randomized, Comparator-Controlled Trial to Determine the Relative Efficacy, Safety, and Immunogenicity of the Investigational Oral SARS-CoV-2 Vaccine Tablet Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection
-
CLINICAL_TRIALS study record update · 2025-08-17Evaluation of the Efficacy of Methylene Blue Administration in SARS-CoV2- Affected Patients: a Phase 2, Randomized, Placebo- Controlled, Single Blind Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-06-06Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a
-
CLINICAL_TRIALS study record update · 2024-09-24A Phase I Double-Blind Randomized Placebo-Controlled Trial of Combination Therapy to Treat COVID-19 Infection
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-05-02A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Dosage-Escalation, Single Centre Study to Evaluate the Safety and Immunogenicity of an Adjuvanted SARS-CoV-2 Sclamp Protein Subunit Vaccine in Healthy Adults Aged 18 to 55 Years Old and Healthy Older Adults, Aged 56 Years and Over
-
CLINICAL_TRIALS study record update · 2023-05-15Adaptive Design Phase 2 to 3, Randomized, Double-blind, to Evaluate Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of BIO101 in the Prevention of the Respiratory Deterioration in Hospitalized COVID-19 Patients
-
CLINICAL_TRIALS study record update · 2023-03-06Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?
-
CLINICAL_TRIALS study record update · 2022-11-02Resistance Training Intervention on the Clinical Status in Patients With Post Discharge Symptoms After Covid-19: The "EXER-COVID Study"
-
CLINICAL_TRIALS study record update · 2022-07-12SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study
-
CLINICAL_TRIALS study record update · 2022-07-01A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of SAB-185 in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2022-02-04A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of LY3819253 Alone and in Combination With LY3832479 in Preventing SARS-CoV-2 Infection and COVID-19 in Skilled Nursing and Assisted Living Facility Residents and Staff; a NIAID and Lilly Collaborative Study
-
CLINICAL_TRIALS study record update · 2021-10-26A Phase 1B, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of SAB-185 in Ambulatory Subjects With COVID-19
-
CLINICAL_TRIALS study record update · 2021-10-01Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection
-
CLINICAL_TRIALS study record update · 2021-09-28Cannabidiol (CBD) in Patients With Mild to Moderate Symptoms of Coronavirus 2019: A Randomized, Double-blind, Placebo-controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2021-06-21Compassionate Use Open-Label Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19)
-
CLINICAL_TRIALS study record update · 2021-06-16Impact of COVID-19 on Pediatric Dental Practice During First, Second And Third Wave Among a Group of Pediatric Dentists : A Cross -Sectional Study
-
CLINICAL_TRIALS study record update · 2021-05-20Clinical Features of Severe Patients With COVID-19
-
CLINICAL_TRIALS study record update · 2021-05-17Assessment of SARS-CoV-2 Effect on Post-traumatic Stress of Patients Hospitalized in Intensive Care
-
CLINICAL_TRIALS study record update · 2021-04-08Randomized, Double-Blind Clinical Trial of Ruxolitinib in Patients With Acute Respiratory Disorder Syndrome Due to SARS-CoV-2 Infection
-
CLINICAL_TRIALS study record update · 2021-04-02An Open-Label, Multicenter, Parallel-Group, Randomized, Phase II/III Study to Evaluate the Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19
-
CLINICAL_TRIALS study record update · 2021-02-03Anti-Androgen Treatment for COVID-19
-
CLINICAL_TRIALS study record update · 2020-11-13Prevention, Efficacy and Safety of BCG Vaccine in COVID-19- Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2020-11-09Prospective Evaluation of the Predictive Criteria of Severity Related to Patient Calling Emergency Centre for Low or High Respiratory Infection With or Without Fever and Suspected to be COVID-19.
-
CLINICAL_TRIALS study record update · 2020-09-09A Multicenter, Double-blind, Randomized, Placebo-controlled Clinical Trial to Protect Health Workers Against COVID-19 by Using Previfenon® as Chemoprophylaxis During a SARS-CoV-2 Outbreak. The HERD Study